Aprea Therapeutics Announces Presentations on its Next Gener

Aprea Therapeutics Announces Presentations on its Next Generation WEE1 Inhibitor, APR-1051, and A Novel Macrocyclic ATR Inhibitor, ATRN-119, at AACR Annual Meeting 2024

Aprea Therapeutics Announces Presentations on its Next Generation WEE1 Inhibitor, APR-1051, and A Novel Macrocyclic ATR Inhibitor, ATRN-119, at AACR Annual Meeting 2024

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Pennsylvania , United States , San Diego , California , American , Oren Gilad , Nadeemq Mirza , Molly Hansbarger , Mike Moyer , Nadeem Mirza , Fiona Simpkins , Dennis Riedl , Timothy Yap , Teresa Lee , Center Evaluation , Exchange Commission , Aprea Therapeutics Inc , Securities Exchange , Md Anderson Cancer Center , American Association Of Cancer Research , Nasdaq , Zentalis Pharmaceuticals , Cycline Overexpressing , Dose Limiting Toxicities , American Association , Cancer Research , Annual Meeting , Multi Center Evaluation , Advanced Solid Tumors , Bayesian Optimal Interval , Recommended Phase , Cancer Center , Senior Medical Advisor , Securities Act , Securities Exchange Act , Financial Condition ,